Arkolith/Insider Trading/TIL/Form 4

Shah Nimish P

DirectorInstil Bio, Inc. (TIL) · full profile →Form 4 · filed Mar 25, 2021
Net Buying
Open-Market Buys
$6.0M
Open-Market Sells
$0
Net Open-Market Flow
$6.0M
Transactions
15
10 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2021Conversion(C)5.1M——5.1M
Mar 23, 2021Conversion(C)510K——510K
Mar 23, 2021Conversion(C)430K——5.5M
Mar 23, 2021Conversion(C)43K——553K
Mar 23, 2021Conversion(C)481K——481K
Mar 23, 2021Buy(P)105K$20.00$2.1M5.6M
Mar 23, 2021Buy(P)20K$20.00$392K20K
Mar 23, 2021Buy(P)10K$20.00$209K564K
Mar 23, 2021Buy(P)117K$20.00$2.3M598K
Mar 23, 2021Buy(P)48K$20.00$968K48K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 23, 2021Conversion(C)36K—$00
Mar 23, 2021Conversion(C)401K—$00
Mar 23, 2021Conversion(C)4.3M—$00
Mar 23, 2021Conversion(C)359K—$00
Mar 23, 2021Conversion(C)425K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-023065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML